Lamivudine/zidovudine price cut, gefitinib free for poorer patients

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 414, 2003 , pp. 12-12(1)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Cost-allocation; Gefitinib, therapeutic use; HIV-infections, treatment; Lamivudine/zidovudine, therapeutic use; Non-small-cell-lung-cancer, treatment; Pharmaceutical-industry

Language: English

Document Type: Short communication

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$34.95 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A